Neuropsychiatric symptoms (NPS) such as depression, anxiety, apathy, psychosis or behavioral disorders are among the most common concomitant symptoms of neurocognitive disorders and have just as strong an impact on prognosis as cognitive deficits. The genetic variant of apolipoprotein E (APOE) is the most important risk factor for Alzheimer’s disease, but also influences the occurrence of NPS in various neurodegenerative diseases. A recent review summarizes the proven associations between APOE genotypes and neuropsychiatric symptoms and discusses the clinical relevance.
Autoren
- Tanja Schliebe
Publikation
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
- "Survey of Health, Ageing and Retirement in Europe" (SHARE)
Analysis of polypharmacy in ≥65-year-olds
- New perspectives for clinics and research
Ageing, cellular senescence and Parkinson’s disease
- From early intervention to individualization
The new guidelines at a glance
- Artificial intelligence
Dr. ChatGPT: Large language models in everyday clinical practice
- COPD therapy
Drug therapy – Update 2025
- Focus on prevention
Colorectal cancer screening – an update
- From symptom to diagnosis
Oncology – Thymoma
- Shared decision making